Blog

Atai’s Pipeline Update – Weekly Extractions: October 19, 2022

Oct 19 • 1 min read

In this edition of Weekly Extractions, host Adam Tubero provides an analysis on atai Life Science‘s ($ATAI) recent pipeline updates. More specifically, the following developments are discussed: KUR – 101(Mitragynine) INB – 01 (Nasal Spray delivery method) intelGenX’s Oral dissolvable DMT film Below is Atai’s 3-month stock chart straight from their Psychedelic Invest profile page….

What Does the Future of Psychedelics Look Like?: A Mindshifting Moments Special Event

Oct 19 • 1 min read

In this special edition of Mindshifting Moments featuring host Margaret Williamson… Mindshifting Moments extends an invite to Dr. Ivan Casselman of Havn Life and Psychedelic Invest‘s very own Adam Tubero. This Conversation Series answers the question “What does the future of psychedelics look like?” We’ll Be Back To Regularly Scheduled Episodes Next Week We’ve been…

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial for Its Sol-gel Based Direct-to-Brain Drug Delivery Technology

Oct 18 • 3 min read

atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders today announced the initiation of the Phase 1 proof-of-concept (PoC) clinical trial of intranasal INB-01, a sol-gel based, excipient (drug-delivery) technology. This is a Phase 1 two-stage, open-label, randomized study of the safety, tolerability, and effective brain…

Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety Therapeutics

Oct 18 • 2 min read

Silo Pharma, Inc. (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced it has entered into an agreement with Columbia University pursuant to which Silo has been granted an extension for its option to license certain assets currently under development, including Alzheimer’s disease and Stress Induced Anxiety “The first steps…

Silo Pharma Stock Higher After Investors Appraise Innovative Treatment For Nerve Pain And Neurological Disorders

Oct 18 • 5 min read

Silo Pharma (NASDAQ: SILO) shares are catching a bid, moving 16% higher to reach $6.39 on Tuesday. The move isn’t surprising; SILO is attracting the right kind of attention by doing things differently. And in the pharmaceutical sector, where billions of potential revenue dollars are at stake, different is good. But even more than different, SILO intends to…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560